Explore scientific data around our next generation products. Use the filters below to narrow things down, or simply search via keyword.
Organ-on-a-chip modelling of early atherosclerosis events reveals reduced activity of e-vapour products compared to cigarettes
ViewAssessment of innovative Next Generation nicotine delivery products using ToxTracker
ViewAssessment of the Cardiovascular impact of e-vapour and heated tobacco products using New Approach Methodologies
ViewChemical characterisation of a ceramic wick e-vapour product aerosol reveals marked reductions in toxicant levels when compared to cigarette smoke CORESTA 2024
ViewFactors of initiation to vaping products among smokers
ViewToxicological assessment of a range of next generation product aerosols reveals marked reductions in biological activity CORESTA 2024
ViewEVP’s Impact on US Adult cigarette prevalence Insights from Machine Learning Analysis
ViewTrends in relative risk perceptions of EVP among US adults Analysis of the Population Assessment of Tobacco and Health (PATH) Study Data, 2013-2021 CORESTA 2024
ViewOptimisation and validation of the µFlow in vitro micronucleus test using TK6 cells CORESTA 2024
ViewNon-combustible next generation products induced lower biological activity in the ToxProfiler assay CORESTA 2024
View
